Seelos Therapeutics — Company Overview, News & Financial Data

Seelos Therapeutics (NASDAQ:SEEL) is a biopharmaceutical company deeply engaged in the development of therapies addressing unmet needs in central nervous system (CNS) disorders and rare diseases. Their dynamic pipeline includes projects targeting conditions such as amyotrophic lateral sclerosis (ALS), major depressive disorder (MDD), Parkinson's disease, and other profound medical challenges. Seelos Therapeutics is committed to innovative research and development, aiming to bring groundbreaking treatments to patients who currently have limited or no therapeutic options. Through a focused and patient-centric approach, their objective is to revolutionize the treatment landscape for these serious conditions and improve the quality of life for patients and their families worldwide.